Gaudium IVF & Women Health has debuted at Rs 83.00 on the BSE, up by 4 points or 5.06% from its issue price of Rs 79.00.
The scrip is currently trading at Rs. 80.75, up by 1.75 points or 2.22% from its issue price.
It has touched a high and low of Rs. 87.15 and Rs. 79.05 respectively. So far 4.19 lakh shares were traded on the counter.
The offering, which was open for subscription between February 20, 2026 and February 24, 2026 was subscribed 7.27 times. The issue price was fixed at Rs 79.00 per share i.e. at upper end of price band of Rs 75-79 apiece.
Gaudium IVF & Women Health is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8303.55 |
| Max Healthcare Inst | 977.05 |
| Narayana Hrudayalay | 1970.05 |
| Aster DM Healthcare | 753.60 |
| Global Health | 1239.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: